Research and Markets: The Dawn of Consolidation in the Spinal Surgery Market: Nuvasive to Acquire Cervitech

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/66ca28/the_dawn_of_consol) has
announced the addition of GlobalData's new company profile "The Dawn Of
Consolidation In The Spinal Surgery Market: Nuvasive To Acquire Cervitech" to
their offering.

Acquiring and partnering to expand product portfolio, strengthen R&D pipeline
and venture into newer markets is a trend that's definitely not new. It's also
regarded as one of the best defensive strategies to counter the competitors'
organic growth. The challenge that is most discussed in boardrooms is to
identify the right partner with the right product portfolio so that the best
strategic fit can be obtained and maximum benefits can be reaped from the deal.
Our deal analysis reports are our independent analysis of the latest Mergers &
Acquisitions deals within the global medical equipment industry. We keep our
clients abreast of the very latest consolidation landscape by providing them
with our independent and unbiased judgment on the past, present and future of
the most important Mergers & Acquisitions deals within the medical equipment
industry.

Scope:

* In depth analysis of the latest and the most important Mergers and
Acquisitions deal;
* Analysis of the operations of the companies involved in the deal, their deal
making strategies and the markets they are venturing into;
* Review and analysis of the profiled deal supplemented with a strategic
rationale analysis and impact assessment study; and
* Mapping of the prevalent and expected market and competitive landscape(s), the
deal is likely to have an impact on

Reasons to buy:

* Plan your business strategies by understanding your competitors' deal making
approach, acquisition trends and market entry/expansion strategies;
* Identify the latest consolidation trends in the market(s) you compete in;
* Exploit Mergers and Acquisitions opportunities by understanding the strategic
rationale and success factors behind each deal; and
* Design your inorganic strategies by screening potential acquisition prospects
in the market(s) you compete in.

Key Topics Covered:

1.1 List of Tables

1.2 List of Figures

2 The Dawn Of Consolidation In The Spinal Surgery Market: Nuvasive To Acquire
Cervitech

2.1 Summary

2.2 Nuvasive Company Profile

2.3 Nuvasive Recent Product Launches

2.4 Cervitech Company Profile

2.5 Strategic Rationale For The Deal

2.5.1 Increasing Competition in the Spinal Market

2.5.2 Complementary Product Portfolio

2.5.3 Growing Acceptance for Spinal Non Fusion Surgeries

2.5.4 High Growth Within The Artificial Disc Replacement

2.5.5 Accelerated Entry in to Non Fusion Market

2.6 Future Outlook

3 Appendix

For more information visit
http://www.researchandmarkets.com/research/66ca28/the_dawn_of_consol

Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716

Copyright Business Wire 2009